| InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication Fort Collins, CO. InVitria's product line was featured in the Jan. 15, 2009 edition of Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, entitled "Culture Media Underlies Productivity Gains," referenced the productivity and safety improvements achieved through cell culture media optimization. New media components, such as InVitria's animal free recombinant media, have contributed to these improvements. Test results have confirmed that InVitria's recombinant albumin (CellastimTM) outperforms plasma-derived human serum albumin and results in productivity improvements in CHO and hybridoma cell lines. InVitria's recombinant lactoferrin (LacrominTM) is a strong cell growth factor and is capable of performing better in cell culture media than insulin and insulin-like growth factors. Research has shown LacrominTM to be a major advance in promoting cell growth and productivity across a variety of cell lines. Also mentioned in the article is InVitria's LysobacTM, a cell lysis reagent used in microbial fermentation to improve recombinant protein yield and deliver consistent quality, as well as the safety of an animal free reagent. LysobacTM is many times more active than chicken lysozyme. InVitria's performance enhancing recombinants offer producers affordable, well-defined and regulatory compliant cell culture media and bacterial lysis components. They can also contribute to operational efficiency and reduced capital costs. "InVitria is committed to improving our customers' cell culture and bacterial fermentation performance by producing safe, consistent and affordable components," said Scott Deeter, President of InVitria. "We have been greatly encouraged by the results InVitria customers have achieved using our products. We hope to build upon these successes and share with the bioprocessing, diagnostic and stem cell and regenerative medicine communities the power of InVitria's products." About InVitria Learn more about InVitria's products at www.InVitria.com. Contact InVitria's product customer service specialists by e-mail or phone. E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Phone: 1-800-916-8311
|
-
Blog: The Cell Culture Dish
Strategies for Improving Viral Yield in Vaccine Manufacturing
A recent article in Pharma Times titled "US biopharma: nearly 300 vaccines in R&D," points out that there are currently 300 vaccines either in clinical studies or under review by the Food and Drug Administration (FDA). While not all vaccines are cell culture derived vaccines, it does indicate that a large number of cell culture based viral vaccines are in the pipeline and that perhaps viral vaccine manufacturing should be examined. One area under consideration is how to improve viral yield so that vaccines can be made at lower cost ... Read More
-
Latest News
InVitria Attends the 13th Bi-Annual Cell Culture Engineering Conference
March 29, 2012 - InVitria is attending the 13th Bi-Annual Cell Culture Engineering Conference in Scottsdale, Arizona April 22nd through the 27th. This event is an invitation only conference that includes approximately 350 of the world's top academic and industry cell culture scientists. Topics at the conference range from fundamental science to the engineering challenges of cell culture process development.... read more
